Barbara Pistilli
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 101
- HER2/EGFR in Cancer Research 44
- Cancer Treatment and Pharmacology 31
- Cancer survivorship and care 15
-
- Advanced Breast Cancer Therapies 54
- Co-authors
- Martine Piccart (3 shared papers)Hope S. Rugo (14 shared papers)Mario Campone (10 shared papers)Elie Rassy (10 shared papers)Gabriel N. Hortobágyi (5 shared papers)Bohuslav Melichar (2 shared papers)Fedro A. Peccatori (3 shared papers)José Baselga (2 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Annals of Oncology (20 papers)Cancer Research (13 papers)ESMO Open (11 papers)Cancer Treatment Reviews (5 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Barbara Pistilli
119 papers receiving 1.8k citations
Barbara Pistilli's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 1.2k
- Cancer Research 443
- Pulmonary and Respiratory Medicine 818
- Genetics 150
- Reproductive Medicine 101
Countries citing papers authored by Barbara Pistilli
This map shows the geographic impact of Barbara Pistilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Pistilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Pistilli more than expected).
Fields of papers citing papers by Barbara Pistilli
This network shows the impact of papers produced by Barbara Pistilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Pistilli. The network helps show where Barbara Pistilli may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Pistilli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis Hit paper breakdown → | 2013 | 383 |
| 2 | 2012 | 166 | |
| 3 | 2019 | 119 | |
| 4 | 2013 | 75 | |
| 5 | 2017 | 50 | |
| 6 | 2022 | 47 | |
| 7 | 2019 | 44 | |
| 8 | 2015 | 43 | |
| 9 | 2012 | 41 | |
| 10 | 2014 | 38 | |
| 11 | 2022 | 37 | |
| 12 | 2020 | 36 | |
| 13 | 2019 | 35 | |
| 14 | 2022 | 33 | |
| 15 | 2020 | 31 | |
| 16 | 2023 | 30 | |
| 17 | 2020 | 28 | |
| 18 | 2017 | 25 | |
| 19 | 2024 | 25 | |
| 20 | 2021 | 24 |
About Barbara Pistilli
Barbara Pistilli is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Molecular Biology, having authored 133 papers that have together received 1.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (54 papers), HER2/EGFR in Cancer Research (44 papers), Cancer Treatment and Pharmacology (31 papers), Breast Cancer Treatment Studies (26 papers), Cancer survivorship and care (15 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), BRCA gene mutations in cancer (9 papers) and Estrogen and related hormone effects (9 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (443 citations), Pulmonary and Respiratory Medicine (818 citations), Genetics (150 citations) and Reproductive Medicine (101 citations). Barbara Pistilli has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Martine Piccart, Hope S. Rugo, Mario Campone, Elie Rassy, Gabriel N. Hortobágyi, Bohuslav Melichar, Fedro A. Peccatori, José Baselga, Kathleen I. Pritchard and Michael Gnant. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, ESMO Open and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.